InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions
InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions Recana is the first fully integrated platform designed for treating in-stent and native vessel obstructions. Recana Thrombectomy Catheter System is designed to address the challenges of venous in-stent restenosis and residual thrombotic obstructions and […]



